Disseminated histoplasmosis and pneumocystis pneumonia in a child with Crohn disease receiving infliximab.
Tschudy
James
J
Department of Pediatrics/Pediatric Gastroenterology, Wright State University Boonshoft School of Medicine, Dayton, OH, USA.
Michail
Sonia
S
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D002648:Child; D003424:Crohn Disease / Q000188:drug therapy / Q000382:microbiology*; D005658:Fungi; D006658:Histoplasma; D006660:Histoplasmosis / Q000209:etiology*; D006801:Humans; D000069285:Infliximab; D008297:Male; D009894:Opportunistic Infections / Q000209:etiology* / Q000382:microbiology; D011010:Pneumocystis; D011020:Pneumonia, Pneumocystis / Q000209:etiology* / Q000382:microbiology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab